Major Shareholders
Summary of Issued Securities
Ordinary Shares |
|
| Issued shares at 31 March 2020 | 394,834,698 |
| Employee options over ordinary shares at 31 March 2020 |
19,330,750 |
Major Shareholders
The top 20 shareholders in Pharmaxis Ltd on 31 March 2020 are:
| Name |
Number Of Shares '000 |
% Total |
| 1. Citicorp Nominees Pty Limited | 107,538 | 27% |
| 2. Arix Bioscience Holdings Limited | 43,693 | 11% |
| 3. National Nominees Limited | 25,982 | 7% |
| 4. HSBC Custody Nominees (Australia) Limited | 25,523 | 6% |
| 5. JP Morgan Nominees Australia Limited | 13,301 | 3% |
| 6. Moggs Creek Pty Ltd (Moggs Creek Super A/C) | 7,098 | 2% |
| 7. Dr Toby David Cohen | 3,316 | 1% |
| 8. BNP Paribas Nominees Pty Ltd (BNPP NYB Clearing Acc DRP) | 2,658 | 1% |
| 9. Mr Yingkali Li | 2,400 | 1% |
| 10. Healthcare Management Consulting (Australia) Pty Ltd | 2,220 | 1% |
| 11. Ms Beu Xu + Mr Dongning Wu | 2,123 | 1% |
| 12. Pakasoluto Pty Limited (Barkl Family Super Fund) | 2,036 | 1% |
| 13. Joseph Wallace Carson | 2,000 | 1% |
| 14. George Engineering Pty Ltd (PG Super Fund) | 1,750 | 0% |
| 14. Simgon Pty Ltd (RK Super A/C) | 1,750 | 0% |
| 16. Mr Marco Andrea Negro | 1,400 | 0% |
| 17. DR Newnham Super Pty Ltd | 1,527 | 0% |
| 18. Blair House Pty Ltd (Robert Stork SF A/C) | 1,500 | 0% |
| 18. Jarhamche Pty Ltd | 1,500 | 0% |
| 20. Mr Warren Patrick Hackett (Warren Hackett S/F A/C) | 1,455 | 0% |
Note: the above tables are updated after each quarter end
Substantial Shareholders
| Name | Percent | Date |
| BVF Partners LP | 21% | 30 May 2019 |
| Arix Bioscience Holdings Limited | 11% | 25 September 2018 |
| Australian Ethical Australian Share Fund | 8% | 25 September 2018 |
| D&A Income Limited | 7% | 28 February 2019 |
Directors' Interests
Current director's interest notices can be found here:
